Gene · 4841
Papers2,010
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,010
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LINC00963 promotes the malignancy and metastasis of lung adenocarcinoma by stabilizing Zeb1 and exosomes-induced M2 macrophage polarization. | Mol Med | 2023 | 36604626 | PubTator, text mining | PubMed |
| MED15::TFE3 Renal Cell Carcinomas: Report of Two New Cases and Review of the Literature Confirming Nearly Universal Multilocular Cystic Morphology. | Int J Surg Pathol | 2023 | 36591911 | PubTator, text mining | PubMed |
| Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases. | Zool Res | 2023 | 36579404 | PubTator, text mining | PubMed |
| Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC. | SN Comput Sci | 2023 | 36573207 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancer. | Hum Cell | 2023 | 36528839 | PubTator, text mining | PubMed |
| LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis. | Thorac Cancer | 2023 | 36516959 | PubTator, text mining | PubMed |
| RNAlight: a machine learning model to identify nucleotide features determining RNA subcellular localization. | Brief Bioinform | 2023 | 36464487 | PubTator, text mining | PubMed |
| NONO regulates multiple cytokine production in sepsis via the ERK1/2 signaling pathway. | Mol Immunol | 2023 | 36459792 | PubTator, text mining | PubMed |
| Genetic and phenotypic spectrum in the NONO-associated syndromic disorder. | Am J Med Genet A | 2023 | 36426740 | PubTator, text mining | PubMed |
| NONO enhances mRNA processing of super-enhancer-associated GATA2 and HAND2 genes in neuroblastoma. | EMBO Rep | 2023 | 36416237 | PubTator, text mining | PubMed |
| Regorafenib with or without a programmed cell death protein 1 antibody as third-line treatment for microsatellite stable metastatic colorectal cancer. | Cancer Med | 2023 | 36373163 | PubTator, text mining | PubMed |
| Paraspeckles interact with SWI/SNF subunit ARID1B to regulate transcription and splicing. | EMBO Rep | 2023 | 36354291 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| SARS-CoV-2, HIV, and HPV: Convergent evolution of selective regulation of cGAS-STING signaling. | J Med Virol | 2023 | 36229923 | PubTator, text mining | PubMed |
| A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. | Nat Biotechnol | 2023 | 36217030 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins. | Haematologica | 2023 | 36073514 | PubTator, text mining | PubMed |
| Regulatory roles of NAT10 in airway epithelial cell function and metabolism in pathological conditions. | Cell Biol Toxicol | 2023 | 35877022 | PubTator, text mining | PubMed |
| Genetic variants in RNA m5 C modification genes associated with survival and chemotherapy efficacy of colorectal cancer. | Cancer Med | 2023 | 35861369 | PubTator, text mining | PubMed |
| Multi-color RNA imaging with CRISPR-Cas13b systems in living cells. | Cell Insight | 2022 | 37192858 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4841/papers?page=16